• SENSEX
    NIFTY 50
Market

Monday's top brokerage calls: Mindtree, Voltas and more

Updated : 2020-04-27 08:31:49

The Indian equity market is likely to open higher on Monday, tracking positive trends in Asian peers amid hopes that Bank of Japan (BOJ) will announce more stimulus steps. Among brokerages, Macquarie and Kotak are bearish on Mindtree post its Q4 earnings, while Jefferies has a 'buy' call on Voltas. Here are the top brokerage calls for today:

 Macquarie on Mindtree:  The brokerage maintained 'underperform' on the stock but cut its target to Rs 670 per share from Rs 734 earlier. It added that the company's Q4 was weaker than expectations despite no impact of COVID-19 on its revenue.
Macquarie on Mindtree: The brokerage maintained 'underperform' on the stock but cut its target to Rs 670 per share from Rs 734 earlier. It added that the company's Q4 was weaker than expectations despite no impact of COVID-19 on its revenue.
 Kotak on Mindtree:  The brokerage maintained a 'reduce' call on the stock with the target at Rs 760 per share. It expects an EBITDA margin of 15.6 percent in FY21 and a revenue decline of over 6 percent in Q1FY21.
Kotak on Mindtree: The brokerage maintained a 'reduce' call on the stock with the target at Rs 760 per share. It expects an EBITDA margin of 15.6 percent in FY21 and a revenue decline of over 6 percent in Q1FY21.
 Jefferies on Voltas:  The brokerage had a 'buy' call on the stock with the target at Rs 615 per share. The air conditioning industry has typically followed pricing discipline in the past weak seasons, the brokerage noted.
Jefferies on Voltas: The brokerage had a 'buy' call on the stock with the target at Rs 615 per share. The air conditioning industry has typically followed pricing discipline in the past weak seasons, the brokerage noted.
 Kotak on Whirlpool:  The brokerage had a 'sell' call on the stock but raised its target to Rs 1,540 per share from Rs 1,260 earlier. It added that the long-term penetration story remains intact for the company.
Kotak on Whirlpool: The brokerage had a 'sell' call on the stock but raised its target to Rs 1,540 per share from Rs 1,260 earlier. It added that the long-term penetration story remains intact for the company.
 Nomura on Cummins:  The brokerage maintained a 'reduce' call on the stock with a target at Rs 358 per share. Weak outlook and exports post COVID-19 lead to the deteriorating outlook, it added.
Nomura on Cummins: The brokerage maintained a 'reduce' call on the stock with a target at Rs 358 per share. Weak outlook and exports post COVID-19 lead to the deteriorating outlook, it added.
 Credit Suisse on ICICI Prudential:  The brokerage maintained 'outperform' call on the stock with target cut to Rs 440 per share from Rs 525 earlier. It also cut the stock's FY21-22 EPS estimate by 20 percent.
Credit Suisse on ICICI Prudential: The brokerage maintained 'outperform' call on the stock with target cut to Rs 440 per share from Rs 525 earlier. It also cut the stock's FY21-22 EPS estimate by 20 percent.
 Credit Suisse on IndiGo:  The brokerage maintained 'outperform' call on the stock but cut its target to Rs 1,500 per share from Rs 1,850 earlier. The target cut for the stock is on likely operational weakness, it added.
Credit Suisse on IndiGo: The brokerage maintained 'outperform' call on the stock but cut its target to Rs 1,500 per share from Rs 1,850 earlier. The target cut for the stock is on likely operational weakness, it added.
 Jefferies on Pharma : Cadila and IPCA may see a reversal in stock move as FDA warns against the use of HCQs for COVID-19 patients outside the hospital/clinical trials, said the brokerage.
Jefferies on Pharma: Cadila and IPCA may see a reversal in stock move as FDA warns against the use of HCQs for COVID-19 patients outside the hospital/clinical trials, said the brokerage.
Live TV
Advertisement